NAD+: Cellular Redox Cofactor Research Guide
By UK Peptide Lab Research Team•22 May 2026•7 min read
What is NAD+?
Nicotinamide Adenine Dinucleotide (NAD+) is a coenzyme present in every living cell and central to cellular bioenergetics. NAD+ is not a peptide; it is a dinucleotide composed of nicotinamide mononucleotide linked to adenosine monophosphate, with a molecular weight of approximately 663 Da. The oxidised form (NAD+) and the reduced form (NADH) function together as the principal electron carriers in cellular respiration.
Beyond redox chemistry, NAD+ serves as a substrate for several enzyme families with major roles in ageing, DNA repair, and metabolic regulation research, which has made it one of the most actively investigated small molecules in cellular biology over the past two decades. UK Peptide Lab supplies NAD+ as research-grade lyophilised powder for in-vitro laboratory use only.
Redox Cofactor and Cellular Respiration
In its primary metabolic role, NAD+ accepts electrons during glycolysis, beta-oxidation, and the citric acid cycle, generating NADH which then delivers those electrons to the electron transport chain at complex I of the inner mitochondrial membrane. The resulting proton gradient drives ATP synthesis. Without a continuous supply of NAD+ as electron acceptor, the major catabolic pathways stall, which is why cellular NAD+ levels are tightly regulated and why NAD+ depletion is a major source of metabolic dysfunction in research models.
NAD+ as Substrate for Sirtuins, PARPs, and CD38
Beyond its redox role, NAD+ is consumed as a substrate by three principal enzyme families. The sirtuins (SIRT1 through SIRT7) are NAD+-dependent deacetylases and ADP-ribosyltransferases that regulate gene expression, mitochondrial biogenesis, and stress responses. The poly(ADP-ribose) polymerases (PARPs) consume NAD+ to attach ADP-ribose chains to target proteins during the DNA damage response. CD38 is a cell-surface enzyme that hydrolyses NAD+ as part of immune signalling and intracellular calcium release pathways.
The consumption of NAD+ by these enzyme families produces competition for the cellular NAD+ pool, which is itself a major research subject. PARP hyperactivation during DNA damage can deplete NAD+ to the point of inhibiting sirtuin activity, linking DNA-repair stress to downstream metabolic and gene-expression consequences.
NAD+ Decline with Ageing
Tissue NAD+ levels decline progressively with ageing in multiple model organisms including rodents and humans. Covarrubias, Perrone, Grozio, and Verdin reviewed this decline in Nature Reviews Molecular Cell Biology in 2020, summarising evidence that NAD+ decline is linked causally to numerous ageing-associated processes in research models, including mitochondrial dysfunction, cognitive decline, sarcopenia, and metabolic disease. Lautrup and colleagues reviewed the specific role of NAD+ in brain ageing and neurodegenerative disease research in Cell Metabolism in 2019.
These reviews position NAD+ repletion strategies as a major axis of ageing research. Both direct NAD+ administration and NAD+ precursor compounds (such as nicotinamide mononucleotide and nicotinamide riboside) are studied in this context, with different pharmacokinetic and bioavailability profiles in cell-culture and animal research models.
Research Applications
NAD+ is studied across a broad range of research contexts. Mitochondrial bioenergetics research uses NAD+ levels as a primary readout of redox state. Sirtuin pathway research uses NAD+ supplementation to probe sirtuin-dependent transcriptional and metabolic effects. DNA damage and PARP-pathway research examines NAD+ depletion as a downstream consequence of genotoxic stress. Ageing and longevity research uses NAD+ as both a biomarker and a research intervention. Research on mitochondrial-derived peptides such as MOTS-C intersects with NAD+ research through shared AMPK and mitochondrial-energy-sensing pathways.
Laboratory Handling
NAD+ is supplied as lyophilised powder. NAD+ is hygroscopic and sensitive to heat and light, so storage conditions are particularly important. Store at -20°C prior to reconstitution, in dark sealed conditions, and protect from moisture. Reconstitute with bacteriostatic water by slowly injecting the diluent down the inner wall of the vial and swirling gently. Store the reconstituted solution at 2-8°C, protect from light, and use promptly, as NAD+ is less stable in solution than peptide compounds. See the peptide storage guide for general lyophilised-compound handling principles.
Sourcing in the UK
UK Peptide Lab supplies research-grade NAD+ at 500 mg per vial with full third-party HPLC documentation published on the product page. Same-day UK dispatch on orders placed before 2pm GMT, free Royal Mail Tracked shipping over £45. For in-vitro laboratory research use only, not for human consumption.
Related Products
Disclaimer: This article is for research and educational purposes only. All information provided is not intended as medical advice. UK Peptide Lab products are not for human consumption and are sold strictly for laboratory research use only.